Cerebellar gamma‐aminobutyric acid: Investigation of group effects in neurodevelopmental disorders
Autism Research · 2023-03 · 16 (3) · 535-542
DOI: 10.1002/aur.2888 ↗At a glance
Journal article in Autism Research, published online on 2023-01-10. Written by Elizabeth W Pang and 8 co-authors. Institution: Division of Neurology/Neuroscience and Mental Health, Hospital for Sick Children, Toronto, Canada. Major MEDLINE topics: Cerebellum, gamma-Aminobutyric Acid, Neurodevelopmental Disorders. Cited 13 times so far (Crossref); 56 references. Funded by: Ontario Brain Institute.
Abstract (original language)
Neurodevelopmental disorders (NDDs) including autism spectrum disorder (ASD), attention‐deficit hyperactivity disorder (ADHD) and obsessive–compulsive disorder (OCD) are thought to arise in part from the disruption in the excitatory/inhibitory balance of gamma‐aminobutyric acid (GABA) and glutamate in the brain. Recent evidence has shown the involvement of the cerebellum in cognition and affect regulation, and cerebellar atypical function or damage is reported frequently in NDDs. Magnetic resonance spectroscopy studies have reported decreases in GABA in cortical brain areas in the NDDs, however, GABA levels in the cerebellum have not been examined. To determine possible group effects, we used a MEGA‐PRESS acquisition to investigate GABA+ levels in a cerebellar voxel in 343 individuals (aged 2.5–22 years) with ASD, ADHD, OCD and controls. Using a mixed effects model, we found no significant differences between groups in GABA+ concentration. Our findings suggest that cerebellar GABA+ levels do not differentiate NDD groups.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Neurology/Neuroscience and Mental Health, Hospital for Sick Children, Toronto, Canada.
- Mouse Imaging Centre, The Hospital for Sick Children, Toronto, Canada.
- Diagnostic Imaging/Neuroscience and Mental Health, Hospital for Sick Children, Toronto and Departments of Medical Imaging and Psychology, University of Toronto, Toronto, Canada.
- Physical Sciences, Sunnybrook Research Institute, Toronto, Canada.
- Department of Psychiatry/Neuroscience and Mental Health, Hospital for Sick Children, Toronto, Canada.
- The Mathison Centre for Mental Health Research and Education, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada.
ORCID profiles: Elizabeth W Pang, Chris Hammill
Funding
- Ontario Brain Institute
Cite
APA
Pang, E. W., Hammill, C., Taylor, M. J., Near, J., Schachar, R., Crosbie, J., Arnold, P. D., Anagnostou, E., & Lerch, J. P. (2023). Cerebellar gamma‐aminobutyric acid: Investigation of group effects in neurodevelopmental disorders. Autism Research, 16(3), 535-542. https://doi.org/10.1002/aur.2888
Vancouver
Pang EW, Hammill C, Taylor MJ, Near J, Schachar R, Crosbie J, et al. Cerebellar gamma‐aminobutyric acid: Investigation of group effects in neurodevelopmental disorders. Autism Research. 2023;16(3):535-542. doi:10.1002/aur.2888
BibTeX
@article{Pang2023,
author = {Pang, Elizabeth W and Hammill, Chris and Taylor, Margot J and Near, Jamie and Schachar, Russell and Crosbie, Jennifer and Arnold, Paul D and Anagnostou, Evdokia and Lerch, Jason P},
title = {Cerebellar gamma‐aminobutyric acid: Investigation of group effects in neurodevelopmental disorders},
journal = {Autism Research},
year = {2023},
volume = {16},
number = {3},
pages = {535--542},
doi = {10.1002/aur.2888}
}
EUVIMED